Glycosyn Inc is a biotechnology company that focuses on enhancing health through human milk science. They develop products based on molecules found naturally in human milk, which offer broad health benefits by promoting the establishment and maintenance of a healthy gut microbial ecology. The company and its partners are conducting studies to explore the use of these molecules in normal healthy nutrition and to combat various childhood and adult diseases, including inflammatory bowel disease, necrotizing enterocolitis, irritable bowel syndrome, infectious diarrhea, and childhood respiratory diseases.

Glycosyn was founded in 2002 by three scientific pioneers, who discovered natural, anti-infective components in human breast milk. In 2007, they hired Dr. John McCoy, a seasoned industry professional, as Chief Scientific Officer.

Dr. McCoy and his team have successfully developed scalable technology for large-scale production of Glycosyn's principal products, human milk oligosaccharides (hMOS), and have established intellectual property to protect these innovations. Glycosyn is dedicated to harnessing the benefits of the thousands of bioactive glycan structures found in human milk to promote health and reduce the risk of infections and inflammatory and metabolic diseases